MyFinsight
Home
Blog
About
Contact
Download
Download image
Revenue From Contract
With Customer...
$677,564K
Revenue
$677,564K
(60.09%↑ Y/Y)
Income (loss) from
operations
$77,221K
(269.28%↑ Y/Y)
Other income, net
$11,647K
(23.07%↑ Y/Y)
Total operating
expenses
$600,343K
(28.04%↑ Y/Y)
Income (loss) before
income taxes
$88,868K
(345.82%↑ Y/Y)
Unrealized gain (loss) on
short-term investments and...
$138K
(181.66%↑ Y/Y)
Collaboration expenses
$229,545K
(78.90%↑ Y/Y)
Selling, general and
administrative
$196,272K
(16.82%↑ Y/Y)
Research and development
$96,853K
(-13.23%↓ Y/Y)
Cost of goods sold
$77,673K
(27.52%↑ Y/Y)
Net income (loss)
$59,005K
(236.61%↑ Y/Y)
Total other
comprehensive income (loss)
$138K
(181.66%↑ Y/Y)
Benefit (provision) for
income taxes
$29,863K
(324.13%↑ Y/Y)
Total comprehensive
income (loss)
$59,143K
(236.39%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Kiniksa Pharmaceuticals International, plc (KNSA)
Kiniksa Pharmaceuticals International, plc (KNSA)